Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Gray Sheet

Executive Summary

FDA expects to complete dossier review of TUV Product Services and SGS Yarsley - two EU Conformity Assessment Bodies - by February, which would clear the way for independent premarket reviews and quality systems inspections by the organizations. The agency estimates 55 premarket reports and 165 quality systems reports will be generated and required to be maintained by EU CABs annually, once the Mutual Recognition Agreement medical device annex is fully underway, according to a Jan. 14 Federal Register notice. A decision on how much longer the confidence-building phase of the MRA should be extended is still under consideration by EU and U.S. reps, but the decision could be made in the next month, according to FDA staffers. The confidence building phase was to end Dec. 7, 2001, however, it likely will be extended by at least one year...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts